October 5, 2007 / 4:53 PM / in 10 years

Zars Parma withdraws plans for IPO

NEW YORK, Oct 5 (Reuters) - Zars Pharma Inc, a Salt Lake City pharmaceutical company, said on Friday it had withdrawn its plans for an initial public offering.

The company, in a filing with the U.S. Securities and Exchange Commission. cited “market conditions” as the reason for the withdrawal.

In August, the company filed to sell 5 million shares for $14 to $16 each. It had planned to list its shares on Nasdaq.

The offering was led by Cowen & Co and CIBC World Markets. (Reporting by Lilla Zuill)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below